採用
必須スキル
Excel
About This Role
The Senior Director, Market Access Strategy Lead, US Lupus is a pivotal role within our Market Access & Reimbursement (MA&R) team, reporting directly to the Head of US MA&R. You will spearhead the US market access strategy for our Lupus products, ensuring optimal access and reimbursement. This role will provide strategic oversight of branded and unbranded marketing material creation for payers and other key channel partners (i.e., PBMs, SPs, GPOs), development of pricing and contracting strategy. You will also work closely with the HEOR team to define data and evidence needs for payers and develop strategies to fill identified caps with the goal of driving optimal access and reimbursement.
You will lead a multidisciplinary organization, guide marketing and contracting strategies, while maintaining matrix oversight of payer insights and patient access. As a key member of both the Franchise and Market Access Leadership teams, you will ensure our strategies are fully integrated with franchise objectives, working closely with various cross-functional partners to drive our mission forward.
What You’ll Do
-
Design and execute comprehensive market access strategies aligning with franchise goals
-
Oversee development of pricing and contracting strategies to achieve profitable reimbursement
-
Lead the development and execution of marketing strategies for payers and channel partners
-
Develop reimbursement marketing strategies to enhance customer experience and patient access
-
Collaborate with account teams to address data gaps and support late-stage pipeline assets
-
Serve as a key member of the US MA&R Leadership Team, influencing strategic decisions
-
Engage with franchise leadership to ensure market access considerations are integrated into brand strategy
-
Partner with the US Medical organization to obtain critical data for payer messaging
-
Collaborate with field account management to effectively deliver key strategies
-
Work with Global Value & Access team to align US input with global plans
-
Partner with market access operations and Trade & Distribution leads to appropriately pull through overall market access strategies
Who You Are
You are a strategic thinker with a passion for leading and shaping market access strategies. Your ability to create a vision and drive alignment makes you a valuable asset to any team. You excel in leadership roles, inspiring and mentoring others to achieve business results.
Required Skills
-
Bachelor’s degree required, MBA or other advanced degree preferred
-
12+ years in U.S. market access, payer marketing, pricing, or related fields within the pharmaceutical or biotech industry
-
Experience leading market access launch strategies for pipeline or newly launched products
-
Experience with access marketing and/or strategy at a major affiliate level
-
Proficient in analytics, decision-making, and problem-solving
-
Deep understanding of buy-and-bill reimbursement pathways, including provider dynamics ad payer policy considerations
-
Experience in healthcare economics, contracting strategy, and payer dynamics
-
Proven ability to lead complex strategic initiatives
-
Excellent long-term strategic planning and influencing skills
Preferred Skills
- Experience in specialty markets; rheumatology and dermatology experience preferred
Job Level: Management
Additional Information:
The base compensation range for this role is: $238,000.00-$327,000.00
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
- Medical, Dental, Vision, & Life insurances
- Fitness & Wellness programs including a fitness reimbursement
- Short- and Long-Term Disability insurance
- A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
- Up to 12 company paid holidays + 3 paid days off for Personal Significance
- 80 hours of sick time per calendar year
- Paid Maternity and Parental Leave benefit
- 401(k) program participation with company matched contributions
- Employee stock purchase plan
- Tuition reimbursement of up to $10,000 per calendar year
- Employee Resource Groups participation
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
総閲覧数
0
応募クリック数
0
模擬応募者数
0
スクラップ
0
類似の求人

Associate Product Manager, Supp Health
Lincoln Financial · Radnor, PA, US

Director, Technical Product Management - AWS DC Engineering Global Products & Services, Data Center Engineering
Amazon · Seattle, WA, USA

VP, Digital Product – Data, Personalization & AI (Travel & Lifestyle Services)
American Express · New York, New York, United States

Vice President, Product Delivery Manager
JPMorgan Chase · New York, NY, United States, US

Senior Director, Product Management - Life Sciences
Talkdesk · Seattle
Biogenについて

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
従業員数
Cambridge
本社所在地
$16.2B
企業価値
レビュー
4.1
47件のレビュー
ワークライフバランス
3.6
報酬
4.7
企業文化
4.1
キャリア
4.4
経営陣
3.8
84%
友人に勧める
良い点
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
改善点
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
給与レンジ
541件のデータ
M3
M4
M5
M6
Senior/L5
M3 · Product Manager M3
0件のレポート
$199,467
年収総額
基本給
$79,787
ストック
$99,734
ボーナス
$19,947
$139,627
$259,307
面接体験
47件の面接
難易度
3.5
/ 5
期間
14-28週間
内定率
36%
体験
ポジティブ 65%
普通 25%
ネガティブ 10%
面接プロセス
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
よくある質問
Tell me about a challenging project
System design question
Coding problem
Why this company
ニュース&話題
#AAD26: Biogen declares Phase 2 lupus success for anti-BDCA2 antibody - Endpoints News
Endpoints News
News
·
2w ago
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
·
3w ago
·
1
Biogen reports positive Phase 2 results for lupus skin drug - Investing.com
Investing.com
News
·
3w ago
Biogen Announces Positive Phase 2 Results for Litifilimab in Cutaneous Lupus Erythematosus at AAD 2026 - dermatologytimes.com
dermatologytimes.com
News
·
3w ago